197 related articles for article (PubMed ID: 17975182)
1. Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial.
Stremmel W; Ehehalt R; Autschbach F; Karner M
Ann Intern Med; 2007 Nov; 147(9):603-10. PubMed ID: 17975182
[TBL] [Abstract][Full Text] [Related]
2. Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis.
Stremmel W; Merle U; Zahn A; Autschbach F; Hinz U; Ehehalt R
Gut; 2005 Jul; 54(7):966-71. PubMed ID: 15951544
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
Carbonnel F; Colombel JF; Filippi J; Katsanos KH; Peyrin-Biroulet L; Allez M; Nachury M; Novacek G; Danese S; Abitbol V; Bossa F; Moreau J; Bommelaer G; Bourreille A; Fumery M; Roblin X; Reinisch W; Bouhnik Y; Brixi H; Seksik P; Malamut G; Färkkilä M; Coulibaly B; Dewit O; Louis E; Deplanque D; Michetti P; Sarter H; Laharie D; ;
Gastroenterology; 2016 Feb; 150(2):380-8.e4. PubMed ID: 26632520
[TBL] [Abstract][Full Text] [Related]
4. Delayed release phosphatidylcholine as new therapeutic drug for ulcerative colitis--a review of three clinical trials.
Stremmel W; Hanemann A; Braun A; Stoffels S; Karner M; Fazeli S; Ehehalt R
Expert Opin Investig Drugs; 2010 Dec; 19(12):1623-30. PubMed ID: 21105858
[TBL] [Abstract][Full Text] [Related]
5. Delayed release phosphatidylcholine in chronic-active ulcerative colitis: a randomized, double-blinded, dose finding study.
Stremmel W; Braun A; Hanemann A; Ehehalt R; Autschbach F; Karner M
J Clin Gastroenterol; 2010; 44(5):e101-7. PubMed ID: 20048683
[TBL] [Abstract][Full Text] [Related]
6. First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses.
Karner M; Kocjan A; Stein J; Schreiber S; von Boyen G; Uebel P; Schmidt C; Kupcinskas L; Dina I; Zuelch F; Keilhauer G; Stremmel W
Am J Gastroenterol; 2014 Jul; 109(7):1041-51. PubMed ID: 24796768
[TBL] [Abstract][Full Text] [Related]
7. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylcholine (lecithin) and the mucus layer: Evidence of therapeutic efficacy in ulcerative colitis?
Stremmel W; Hanemann A; Ehehalt R; Karner M; Braun A
Dig Dis; 2010; 28(3):490-6. PubMed ID: 20926877
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Barrett AC; Bortey E; Paterson C; Forbes WP
Dig Dis Sci; 2016 Jan; 61(1):221-9. PubMed ID: 26563167
[TBL] [Abstract][Full Text] [Related]
10. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
11. Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis.
Miyake N; Ando T; Ishiguro K; Maeda O; Watanabe O; Hirayama Y; Maeda K; Morise K; Matsushita M; Furukawa K; Funasaka K; Nakamura M; Miyahara R; Ohmiya N; Goto H
World J Gastroenterol; 2015 Jan; 21(1):254-61. PubMed ID: 25574099
[TBL] [Abstract][Full Text] [Related]
12. Interferon-beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomized, double-blind, placebo-controlled trial.
Musch E; Andus T; Kruis W; Raedler A; Spehlmann M; Schreiber S; Krakamp B; Malek M; Malchow H; Zavada F; Engelberg Feurle G
Clin Gastroenterol Hepatol; 2005 Jun; 3(6):581-6. PubMed ID: 15952100
[TBL] [Abstract][Full Text] [Related]
13. Erythrocytes-mediated delivery of dexamethasone 21-phosphate in steroid-dependent ulcerative colitis: a randomized, double-blind Sham-controlled study.
Bossa F; Annese V; Valvano MR; Latiano A; Martino G; Rossi L; Magnani M; Palmieri O; Serafini S; Damonte G; De Santo E; Andriulli A
Inflamm Bowel Dis; 2013 Aug; 19(9):1872-9. PubMed ID: 23714676
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Rutgeerts P;
Gastroenterology; 2014 Jan; 146(1):96-109.e1. PubMed ID: 23770005
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
16. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.
Naganuma M; Aoyama N; Suzuki Y; Nishino H; Kobayashi K; Hirai F; Watanabe K; Hibi T
J Crohns Colitis; 2016 Jul; 10(7):828-36. PubMed ID: 26577683
[TBL] [Abstract][Full Text] [Related]
17. Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis.
Braun A; Treede I; Gotthardt D; Tietje A; Zahn A; Ruhwald R; Schoenfeld U; Welsch T; Kienle P; Erben G; Lehmann WD; Fuellekrug J; Stremmel W; Ehehalt R
Inflamm Bowel Dis; 2009 Nov; 15(11):1705-20. PubMed ID: 19504612
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A for induction of remission in severe ulcerative colitis.
Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
[TBL] [Abstract][Full Text] [Related]
19. Infliximab efficacy in pediatric ulcerative colitis.
Eidelwein AP; Cuffari C; Abadom V; Oliva-Hemker M
Inflamm Bowel Dis; 2005 Mar; 11(3):213-8. PubMed ID: 15735427
[TBL] [Abstract][Full Text] [Related]
20. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
Hanauer S; Schwartz J; Robinson M; Roufail W; Arora S; Cello J; Safdi M
Am J Gastroenterol; 1993 Aug; 88(8):1188-97. PubMed ID: 8338086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
